Member Viewpoints Programmable RNA: Where the field is headed and why Massachusetts is positioned to lead Nov 09, 2026
Thought Leadership Five takeaways from Align Summit 2026’s regulators panel on FDA, the SEC, and biotech capital Nov 05, 2026
Policy & Advocacy MassBio statement on the results of the U.S. midterm elections and Massachusetts gubernatorial race Nov 04, 2026
Innovation From Sequencing to Automated Analysis: How biotech’s data revolution is accelerating patient impact Oct 20, 2026
